MingSight-Relin Pharmaceuticals Co., Ltd. Report issue

For profit Phase 1
Founded: China (2011)

Organization Overview

First Clinical Trial
2020
NCT04187443
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Shenzhen MingSight Relin Pharmaceuticals Co., Ltd.